Torthaí cuardaigh - Edward L.G. Pryzdial
- 1 - 8 toradh as 8 á dtaispeáint
-
1
Is the COVID‐19 thrombotic catastrophe complement‐connected? de réir Edward M. Conway, Edward L.G. Pryzdial
Foilsithe / Cruthaithe 2020Revisão -
2
Coagulation and complement: Key innate defense participants in a seamless web de réir Edward L.G. Pryzdial, Alexander Leatherdale, Edward M. Conway
Foilsithe / Cruthaithe 2022Revisão -
3
Dengue virus binding and replication by platelets de réir Ayo Yila Simon, Michael R. Sutherland, Edward L.G. Pryzdial
Foilsithe / Cruthaithe 2015Artigo -
4
-
5
Coagulation initiated on herpesviruses de réir Michael R. Sutherland, Christina M. Raynor, Henriette Leenknegt, J. Fraser Wright, Edward L.G. Pryzdial
Foilsithe / Cruthaithe 1997Artigo -
6
Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway de réir Michael J. Krisinger, Verena Goebeler, Zhen Lu, Scott C. Meixner, Timothy Myles, Edward L.G. Pryzdial, Edward M. Conway
Foilsithe / Cruthaithe 2012Artigo -
7
Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA de réir Manu Thomas Kalathottukaren, Libin Abraham, Piyushkumar R. Kapopara, Benjamin Lai, Rajesh A. Shenoi, Federico I. Rosell, Edward M. Conway, Edward L.G. Pryzdial, James H. Morrissey, Charles A. Haynes, Jayachandran N. Kizhakkedathu
Foilsithe / Cruthaithe 2016Artigo -
8
Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity de réir R.L.R. Carter, Kimberley Talbot, Woosuk S. Hur, Scott C. Meixner, J. Grace van der Gugten, Daniel T. Holmes, Hélène C. F. Côté, Christian J. Kastrup, Tyler Smith, A.Y.Y. Lee, Edward L.G. Pryzdial
Foilsithe / Cruthaithe 2018Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Immunology
Medicine
Biology
Internal medicine
Biochemistry
Chemistry
Coagulation
Complement system
Enzyme
Genetics
Immune system
Platelet
Virology
Virus
Antibody
Cell biology
Flow cytometry
Gene
Molecular biology
Pharmacology
Thrombin
Activated clotting time
Alternative complement pathway
Anaphylatoxin
Annexin
Annexin A2
Antibody-dependent enhancement
Antidote
Antiserum
Apixaban